Ardelyx Provides Update on FDA Appeal for XPHOZAH® (tenapanor) for the Control of Serum Phosphorus in Adult Patients with Chronic Kidney Disease on Dialysis

/PRNewswire/ -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative...

Related Keywords

China ,Japan ,United States ,Canada ,Peter Stein ,Fosun Pharma ,Linkedin ,Drug Administration ,Ardelyx Inc ,Nasdaq ,Prnewswire Ardelyx Inc ,Office Of New Drugs ,Facebook ,Complete Response Letter ,New Drug Application ,New Drugs ,Drug Evaluation ,Kyowa Kirin ,Knight Therapeutics ,Ardelyx ,